Alvarez-Demalde Francisco sold 182,000 shares of VTEX on Nov 9, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
182,000Class A Common Shares
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
91.62%This security and ownership context
Holdings after
16,640Direct
Trade date
Nov 9, 2026Sell
Filed
Nov 12, 2026, 9:05 AM ET3-day reporting delay
Accession
0001193125-26-457173Code S · Transaction 398272
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 198,640 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Derivative exercise182,000$3.55$646,100Trade 398271
Nov 9, 2026Derivative exercise182,000$0.00$0Trade 398274
Nov 9, 2026Sell16,640——Trade 398273
4 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

NYSE: VTEX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NYSE: VTEX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: These securities are held by Mr. Alvarez-Demalde for the benefit of Riverwood Capital GP II Ltd. and/or certain of its affiliates (collectively, "Riverwood"). Mr. Alvarez-Demalde is obligated to transfer the underlying shares upon settlement or any proceeds from the sale thereof as directed by Riverwood. Mr. Alvarez-Demalde disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities by Mr. Alvarez-Demalde for purposes of Section 16 or any other purposes. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from USD $3.90 to USD $3.925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3: These stock options are fully vested. Exercise of these stock options were extended until November 13, 2026.